Jianrong Yang

916 total citations
23 papers, 711 citations indexed

About

Jianrong Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jianrong Yang has authored 23 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Jianrong Yang's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (9 papers) and Epigenetics and DNA Methylation (5 papers). Jianrong Yang is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (9 papers) and Epigenetics and DNA Methylation (5 papers). Jianrong Yang collaborates with scholars based in China and United States. Jianrong Yang's co-authors include Jie Cheng, Yanling Wang, Dongmiao Wang, Hongbing Jiang, Zhongwu Li, Zhongwu Li, Wei Zhang, Jinhai Ye, Pengfei Diao and Yuan Zhang and has published in prestigious journals such as Experimental Cell Research, Journal of Cellular Biochemistry and Cell Death and Disease.

In The Last Decade

Jianrong Yang

22 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianrong Yang China 15 491 270 219 135 90 23 711
Zhongwu Li China 14 488 1.0× 168 0.6× 155 0.7× 130 1.0× 42 0.5× 19 600
Kazuaki Fushimi Japan 15 333 0.7× 131 0.5× 135 0.6× 59 0.4× 68 0.8× 22 486
Takashi Ishigami Japan 13 319 0.6× 111 0.4× 124 0.6× 77 0.6× 76 0.8× 24 525
Kaltin Ferguson Australia 13 276 0.6× 168 0.6× 229 1.0× 31 0.2× 71 0.8× 21 559
Xubin Deng China 17 731 1.5× 583 2.2× 223 1.0× 37 0.3× 67 0.7× 27 948
Ricardo Rezola Spain 10 517 1.1× 287 1.1× 354 1.6× 31 0.2× 50 0.6× 17 793
Fátima Solange Pasini Brazil 13 223 0.5× 157 0.6× 165 0.8× 25 0.2× 50 0.6× 31 444
Iwao Seshimo Japan 7 224 0.5× 125 0.5× 411 1.9× 56 0.4× 120 1.3× 13 631
Agata A. Tinnirello United States 6 397 0.8× 158 0.6× 264 1.2× 91 0.7× 57 0.6× 12 592
Toby Hulf Australia 10 883 1.8× 574 2.1× 98 0.4× 37 0.3× 71 0.8× 11 1.0k

Countries citing papers authored by Jianrong Yang

Since Specialization
Citations

This map shows the geographic impact of Jianrong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianrong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianrong Yang more than expected).

Fields of papers citing papers by Jianrong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianrong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianrong Yang. The network helps show where Jianrong Yang may publish in the future.

Co-authorship network of co-authors of Jianrong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianrong Yang. A scholar is included among the top collaborators of Jianrong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianrong Yang. Jianrong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhongwu, et al.. (2022). HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma. Experimental Cell Research. 418(1). 113271–113271. 14 indexed citations
3.
Wu, Xiang, Jin Li, Xin Li, et al.. (2021). HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma. Cancer Cell International. 21(1). 393–393. 11 indexed citations
4.
Li, Zhongwu, et al.. (2020). Increased expression of FOXD1 is associated with cervical node metastasis and unfavorable prognosis in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 49(10). 1030–1036. 11 indexed citations
5.
Yao, Yao, Zhongyi Yan, Chao Zhou, et al.. (2020). Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 8(2). e000444–e000444. 50 indexed citations
6.
Shen, Hong, Peng Huang, Feng Zang, et al.. (2020). Vitamin D receptor genetic polymorphisms are associated with oral lichen planus susceptibility in a Chinese Han population. BMC Oral Health. 20(1). 26–26. 18 indexed citations
7.
Li, Jin, Zhongwu Li, Yaping Wu, et al.. (2019). Overexpression of lncRNA WWTR1‐AS1 associates with tumor aggressiveness and unfavorable survival in head‐neck squamous cell carcinoma. Journal of Cellular Biochemistry. 120(10). 18266–18277. 13 indexed citations
8.
Li, Jin, Zhongwu Li, Yaping Wu, et al.. (2019). The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma. Cell Death and Disease. 10(8). 603–603. 48 indexed citations
9.
Wu, Yaping, Huijun Hu, Wei Zhang, et al.. (2018). SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma. Journal of Cellular and Molecular Medicine. 22(7). 3582–3594. 21 indexed citations
10.
Yao, Yao, Xinyuan Chen, Shuai Lü, et al.. (2018). Circulating Long Noncoding RNAs as Biomarkers for Predicting Head and Neck Squamous Cell Carcinoma. Cellular Physiology and Biochemistry. 50(4). 1429–1440. 31 indexed citations
11.
Zhou, Chen, Jin Li, Yaping Wu, et al.. (2018). High Density of Intratumor CD45RO+ Memory Tumor-Infiltrating Lymphocytes Predicts Favorable Prognosis in Patients With Oral Squamous Cell Carcinoma. Journal of Oral and Maxillofacial Surgery. 77(3). 536–545. 16 indexed citations
12.
Zhou, Chen, Yaping Wu, Lei Jiang, et al.. (2018). Density and location of CD3+ and CD8+ tumor‐infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 47(4). 359–367. 45 indexed citations
13.
Huang, Rong, Yaping Wu, Pengfei Diao, et al.. (2018). Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma. Pathology. 51(1). 74–80. 31 indexed citations
14.
Wang, Jian, et al.. (2017). Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma. Molecular Medicine Reports. 16(1). 499–506. 11 indexed citations
15.
Hu, Huijun, Zhongwu Li, Yumin Zhu, et al.. (2017). Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma. Cancer Cell International. 17(1). 26–26. 14 indexed citations
16.
Li, Zhongwu, Yanling Wang, Li Lin, et al.. (2016). Overexpression of miR-29b reduces collagen biosynthesis by inhibiting heat shock protein 47 during skin wound healing. Translational research. 178. 38–53.e6. 38 indexed citations
17.
Shi, Liang, Zhanguo Chen, Lili Wu, et al.. (2015). miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant Pathway. Asian Pacific Journal of Cancer Prevention. 15(23). 10439–10444. 80 indexed citations
18.
Li, Zhongwu, Yanling Wang, Yumin Zhu, et al.. (2015). The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Molecular Oncology. 9(6). 1091–1105. 141 indexed citations
19.
Wang, Dongmiao, Yuming Zhu, Yanling Wang, et al.. (2015). The pluripotency factor LIN28B is involved in oral carcinogenesis and associates with tumor aggressiveness and unfavorable prognosis. Cancer Cell International. 15(1). 99–99. 17 indexed citations
20.
Li, Zhongwu, Yanling Wang, Chunping Yuan, et al.. (2014). Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer. Laboratory Investigation. 94(12). 1431–1445. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026